These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9164311)

  • 21. [Statistical notes. Which risks do the patient incur if his own cardiologist accepts to be involved in a clinical trial without deep consideration of the a priori available evidence?].
    Marubini E; Rebora P; Reina G
    G Ital Cardiol (Rome); 2006 May; 7(5):344-7. PubMed ID: 16752517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Day-case transfer for percutaneous coronary intervention with adjunctive abciximab in acute coronary syndromes.
    Blackman DJ; Clarke NR; Orr WP; Wilkinson E; Beswick A; Coppock D; Sprigings DC; Banning AP
    Heart; 2002 Apr; 87(4):375-6. PubMed ID: 11907016
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inhibitors of GPIIb/IIIa platelet receptors].
    Chanu B
    Arch Mal Coeur Vaiss; 1999 Jul; 92(7):893-902. PubMed ID: 10443310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advancing the battle against acute ischemic syndromes: a focus on the GP IIb-IIIa inhibitors.
    Dobesh PP; Latham KA
    Pharmacotherapy; 1998; 18(4):663-85. PubMed ID: 9692642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Superaspirin in the platelet aggregation inhibitor therapy].
    Rossi G
    Recenti Prog Med; 1997 Dec; 88(12):590-1. PubMed ID: 9522603
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials update.
    Kayser SR
    Prog Cardiovasc Nurs; 1997; 12(2):30-3, 44. PubMed ID: 9195645
    [No Abstract]   [Full Text] [Related]  

  • 27. Percutaneous coronary interventions in patients with renal insufficiency: a high-risk, under-studied cohort.
    Steinhubl SR
    Am Heart J; 2003 Aug; 146(2):213-4. PubMed ID: 12891186
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of acute coronary syndromes.
    Schulman SP; Fessler HE
    Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971
    [No Abstract]   [Full Text] [Related]  

  • 29. IIb/IIIa platelet inhibitors in the management of coronary artery disease.
    Talley JD
    J Ark Med Soc; 1996 Oct; 93(5):237-9. PubMed ID: 8908943
    [No Abstract]   [Full Text] [Related]  

  • 30. Are tirofiban and abciximab identical in efficacy?
    Jafary FH
    Eur Heart J; 2006 Jan; 27(1):119-20; author reply 120. PubMed ID: 16278228
    [No Abstract]   [Full Text] [Related]  

  • 31. Abciximab: IIb or not IIb, is that still the question?
    Patel S; Perera D; Redwood S
    Int J Clin Pract; 2003; 57(1):5-7. PubMed ID: 12587933
    [No Abstract]   [Full Text] [Related]  

  • 32. Antithrombotic therapy in acute coronary syndromes.
    Sabatine MS; Jang IK
    Acta Cardiol; 1999 Feb; 54(1):3-29. PubMed ID: 10214473
    [No Abstract]   [Full Text] [Related]  

  • 33. Tensions remain over tPA for stroke.
    Mitka M
    JAMA; 2003 Mar; 289(11):1363-4. PubMed ID: 12636438
    [No Abstract]   [Full Text] [Related]  

  • 34. Antithrombotic agents in coronary artery disease.
    Cairns JA; Lewis HD; Meade TW; Sutton GC; Théroux P
    Chest; 1995 Oct; 108(4 Suppl):380S-400S. PubMed ID: 7555191
    [No Abstract]   [Full Text] [Related]  

  • 35. New antithrombotic drugs for systemic and local delivery for coronary artery disease.
    Shah PK
    J Interv Cardiol; 1995 Aug; 8(4):427-37. PubMed ID: 10155257
    [No Abstract]   [Full Text] [Related]  

  • 36. [Path of exploration for the optimal antithrombotic treatment strategy for patients with coronary heart disease].
    Li Y; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):429-431. PubMed ID: 35589590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances and perspectives of antithrombotic therapy for coronary artery diseases in China].
    Li Y; Zhao R; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Sep; 47(9):683-688. PubMed ID: 31550834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TARGET follow-up study.
    Hautvast R; Jessurun G; Tio R
    Lancet; 2002 Dec 21-28; 360(9350):2085-6; author reply 2086. PubMed ID: 12504451
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic efficiency of tirofiban in acute coronary syndromes.
    Biondi-Zoccai GG; Agostoni P
    Lancet; 2000 Mar; 355(9207):931. PubMed ID: 10752730
    [No Abstract]   [Full Text] [Related]  

  • 40. Don't stop antithrombotics for cutaneous surgery: just do it now!
    Amici JM
    Br J Dermatol; 2015 Mar; 172(3):555-6. PubMed ID: 25776235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.